alexa Colin Collins | Vancouver Prostate Centre
ISSN: 2168-9857

Medical & Surgical Urology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Colin Collins

Colin Collins Colin Collins, PhD
Professor
Department of Urologic Sciences
Vancouver Prostate Centre
Canada
Biography

Dr Collins is a Professor at the University of British Columbia and a Senior Scientist at the Vancouver Prostate Centre where he directs The Laboratory for Advanced Genome Analysis He is an associate adjunct professor at the University of California San Francisco Comprehensive Cancer Center His research is best described as translational genomics where mathematics genomics computer science and clinical science converge in diagnostics and therapeutics He identified and patented of a suite of DNA based biomarkers for predicting a prostate cancer patient’s risk of metastasis He invented and patented End Sequence Profiling ESP the forerunner of pairedend sequencing to determine the physical structure of tumour genomes Dr Collins is now integrating arraybased technologies and next generation sequencing technologies to make personalized oncology a reality in the near term He has received multiple patents and awards including the California Cancer Research Programs Cornelius L Hopper Scientific Achievement Award for Innovation

Research Interest

His research is best described as translational genomics where mathematics, genomics, computer science, and clinical science converge in diagnostics and therapeutics. He identified and patented of a suite of DNA based biomarkers for predicting a prostate cancer patient’s risk of metastasis. He invented and patented End Sequence Profiling (ESP) the forerunner of paired-end sequencing to determine the physical structure of tumour genomes. Dr Collins is now integrating array-based technologies and next generation sequencing technologies to make personalized oncology a reality in the near term.

Certificate
Certificate

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords